BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29848166)

  • 21. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetics and lupus.
    Miceli-Richard C
    Joint Bone Spine; 2015 Mar; 82(2):90-3. PubMed ID: 25523441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Orlowski RJ; O'Rourke KS; Olorenshaw I; Hawkins GA; Maas S; Laxminarayana D
    Immunology; 2008 Nov; 125(3):408-19. PubMed ID: 18462347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Long Noncoding RNA lincRNA00892 Activates CD4
    Liu X; Lin J; Wu H; Wang Y; Xie L; Wu J; Qin H; Xu J
    Front Pharmacol; 2021; 12():733902. PubMed ID: 34707498
    [No Abstract]   [Full Text] [Related]  

  • 26. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Kammer GM; Tsokos GC
    J Autoimmun; 2001 Mar; 16(2):133-42. PubMed ID: 11247639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Transcriptome Profiling Revealed That Elevated Long Non-Coding RNA-
    You Y; Zhao X; Wu Y; Mao J; Ge L; Guo J; Zhao C; Chen D; Song Z
    Front Immunol; 2021; 12():615859. PubMed ID: 34220794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.
    Amr KS; Bayoumi FS; Elgengehy FT; Abdallah SO; Ahmed HH; Eissa E
    Rheumatol Int; 2016 Nov; 36(11):1617-1625. PubMed ID: 27510529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vβ T cell receptor (TCR) genes in circulating cells of patients with systemic lupus erythematosus and their healthy relatives].
    Jakez-Ocampo J; Paulín-Vera CM; Rivadeneyra-Espinoza L; Gómez-Martín D; Carrillo-Maravilla E; Lima G; Vargas-Rojas MI; Pérez-Romano B; Calva-Cevenini G; García-Carrasco M; Ruiz-Argüelles A; Llorente L
    Gac Med Mex; 2018; 154(1):74-79. PubMed ID: 29420529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
    Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
    Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients.
    Wu Z; Mei X; Zhao D; Sun Y; Song J; Pan W; Shi W
    J Dermatol Sci; 2015 Feb; 77(2):110-6. PubMed ID: 25595738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.
    Enyedy EJ; Nambiar MP; Liossis SN; Dennis G; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 May; 44(5):1114-21. PubMed ID: 11352243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Hirashima M; Fukazawa T; Abe K; Morita Y; Kusaoi M; Hashimoto H
    Lupus; 2004; 13(1):24-31. PubMed ID: 14870914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.